Loading clinical trials...
Loading clinical trials...
Karma CREME-1: A Double-blind, Placebo-controlled, Three-armed, Pilot Study of the Effects, Safety and Tolerability of Topical Endoxifen in Women Within the Karma Cohort
Conditions
Interventions
Topical endoxifen
Placebo
Locations
1
Sweden
Karolinska Institutet
Stockholm, Sodersjukhuset, Sweden
Start Date
April 9, 2018
Primary Completion Date
September 10, 2018
Completion Date
September 4, 2019
Last Updated
July 12, 2021
Lead Sponsor
Atossa Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions